21 Sep 2022 by admin in UncategorizedComments OriCell Therapeutics Receives Implied License from NMPA for Ori-C101 IND Application
16 Sep 2022 by admin in UncategorizedComments Syros Announces Closing of Merger with Tyme Technologies and Concurrent Private Placement
15 Sep 2022 by admin in UncategorizedComments Syros and Tyme Technologies Announce Stockholder Approval of Merger
07 Sep 2022 by admin in UncategorizedComments Zenas BioPharma Appoints Simon Lowry, M.D. as Chief Medical Officer
